Publicacións nas que colabora con Miguel Ángel Piris Pinilla (13)

2015

  1. Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation

    Haematologica, Vol. 100, Núm. 5, pp. e200-e203

2014

  1. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation

    Leukemia, Vol. 28, Núm. 6, pp. 1334-1340

2012

  1. Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: Development and validation on 593 cases

    British Journal of Haematology, Vol. 159, Núm. 2, pp. 164-171

2005

  1. Large B-cell lymphoma with Hodgkin's features

    Histopathology, Vol. 47, Núm. 1, pp. 101-110

2004

  1. Building an Outcome Predictor Model for Diffuse Large B-Cell Lymphoma

    American Journal of Pathology, Vol. 164, Núm. 2, pp. 613-622

  2. Influence of biologic markers on the outcome of Hodgkin's lymphoma: A study by the Spanish Hodgkin's Lymphoma Study Group

    Journal of Clinical Oncology, Vol. 22, Núm. 9, pp. 1664-1673

2003

  1. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: Analyses using tissue microarrays

    Blood, Vol. 101, Núm. 2, pp. 681-689

2002

  1. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: Differential diagnosis from Hodgkin's lymphoma

    Histopathology, Vol. 41, Núm. 3, pp. 216-229

2001

  1. Primary cutaneous large B-cell lymphoma: The relation between morphology, clinical presentation, immunohistochemical markers, and survival

    American Journal of Surgical Pathology, Vol. 25, Núm. 3, pp. 307-315

2000

  1. Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy

    Leukemia and Lymphoma, Vol. 39, Núm. 5-6, pp. 563-572

1997

  1. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr Virus-latent membrane protein 1 expression

    Blood, Vol. 90, Núm. 6, pp. 2429-2436

1995

  1. Mucosal mantle cell (centrocytic) lymphomas

    Histopathology, Vol. 26, Núm. 5, pp. 413-422

1994

  1. Monocytoid B cells: A comparative clinical pathological study of their distribution in different types of low-grade lymphomas

    American Journal of Surgical Pathology, Vol. 18, Núm. 11, pp. 1131-1139